Trial
NCT04938102
Role of EndoFLIP in the Diagnostic Paradigm of Esophagogastric Junction Outflow Obstruction
UnknownWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Kansas Medical Center
Collaborators
—
Condition
Esophagogastric Junction Disorder
Intervention
Botulinum Toxin Type A Injection [Botox]
Why stopped
Administrative-not IRB approved
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-10-21